Mesothelioma specialists have conducted a study that may be of interest to those in Louisville who know someone with this cancer. Results of the study have been published in the Annals of Surgical Oncology revealing that many mesothelioma patients 80 years and older are dying without receiving any cancer-related treatments. These treatments could have increased the median survival rate, which came to only 4.1 months.
The European Society for Radiotherapy and Oncology held its annual ESTRO 38 conference, during which a study was presented that may intrigue mesothelioma patients in Louisville. The study found that radiotherapy, which has been used to control the symptoms of mesothelioma, may actually do much more that is positive for patients.
Workers in Louisville who were exposed to asbestos continue to suffer a risk for mesothelioma that does not decline despite stopping the exposure. In many cases, ending exposure to a carcinogen lowers the risk of a cancer diagnosis, as in the case of quitting smoking. Mesothelioma is a rare cancer that is generally caused by asbestos exposure. In most cases, it is linked to exposure in the workplace. Because the mineral was not flammable, did not corrode and provided strong insulation, it was mined and used in pipes, insulation and a range of industrial activities.
Louisville residents may be familiar with mesothelioma, a cancer caused usually by exposure to asbestos. The most common type is pleural mesothelioma, which affects the lining of the lungs. This type can be divided into three subtypes. Normally, chemotherapy is used to treat pleural mesothelioma, but new research finds some of these subtypes do not respond so well to the treatment.
Louisville residents may want to know about a new form of immunotherapy that has been shown to be effective in treating malignant pleural mesothelioma. CAR T-cell therapy involves a laboratory reprogramming of a patient's T cells, a certain type of white blood cell, so that they attack a surface protein in the cancer called mesothelin.
Mesothelioma is difficult for doctors to diagnose in its early stages. Therefore, patients in Kentucky and elsewhere may have a harder time getting the care that they need to overcome the condition. However, medical professionals are using machine learning that may be able to help them spot the condition sooner. In fact, some believe that the data the machines provide may make it possible to diagnose mesothelioma without their help.
Patients who suffer from mesothelioma in Louisville and across the country may soon have access to a promising new treatment. Every year, approximately 3,000 people in the United States are diagnosed with mesothelioma. When found early, mesothelioma has a 41 percent two-year survival rate. When found in a later stage when a solid mass has formed, the survival rate drops to 17 percent.
Mesothelioma patients in Louisville may have access to improved treatment in the years ahead based on research into a blood-clotting pathway. Researchers at the Langone Medical Center in New York and the Cancer and Vascular Biology Research Center in Haifa, Israel, report that initial results were promising and that additional research is needed, including human clinical trials.
Public health researchers from Italy have found that the risk of dying from mesothelioma rises and then falls over the decades following exposure to asbestos, yet these peaks and valleys differ based on the type of mesothelioma. Workers in Louisville who are exposed to asbestos may develop one of several types of this cancer. For instance, it may affect their peritoneum (the membrane lining the abdomen), pleurae (the lining of the lungs), or pericardium (the sac containing the heart). The chances of developing lung cancer are also high.
In December 2018, documents came to light showing that Johnson & Johnson has long had concerns about its talc-based products containing small amounts of asbestos. Some of these concerns date as far back as the 1970s. Now, the company is facing more than 13,000 lawsuits from consumers who claim to have been harmed by those products. Louisville residents might be interested to learn that one of those lawsuits has ended in a $29.4 million settlement.